@article{fd8560553ce54ed08dfee7f631295f40,
title = "Vertebrobasilar atherosclerotic disease: Is it time to revisit angioplasty?",
keywords = "Angioplasty, Blood Flow, Magnetic Resonance Angiography, Stroke",
author = "Sepideh Amin-Hanjani and Siddiqui, {Adnan H.} and Turan, {Tanya N.} and Henry Woo and Shyam Prabhakaran and Derdeyn, {Colin P.} and Charbel, {Fady T.}",
note = "Funding Information: Competing interests SA-H—grant funding: NIH/ NINDS (NS 059745); material research support (no direct funds): VasSol, Inc. AHS—consultant: Codman, Medtronic, GuidePoint Global Consulting, Penumbra, Stryker, Microvention, W.L. Gore Associates, Three Rivers Medical, Inc, Corindus, Inc, Amnis Therapeutics, Ltd, CereVasc, LLC, Pulsar Vascular, The Stroke Project, Inc, Cerebrotech Medical Systems, Inc, Rapid Medical, Neuravi, Silk Road Medical, Rebound Medical; Financial interest: StimSox, Valor Medical, NeuroTechnology Investors, Cardinal, Medina Medical Systems, Buffalo Technology Partners, Inc, International Medical Distribution Partners; National Steering Committee: 3D Separator Trial, SWIFT PRIME and SWIFT DIRECT Trials, CONFIDENCE Study, LARGE Trial, POSITIVE Trial, COMPASS Trial, INVEST Trial; board membership: Intersocietal Accreditation Committee.",
year = "2017",
month = nov,
doi = "10.1136/neurintsurg-2016-012624",
language = "English (US)",
volume = "9",
pages = "1033--1034",
journal = "Journal of NeuroInterventional Surgery",
issn = "1759-8478",
publisher = "BMJ Publishing Group",
number = "11",
}